coronaviru
pose
threat
individu
chronic
health
condit
like
develop
sever
pneumonia
death
pulmonari
arteri
hypertens
repres
highrisk
group
sever
present
respiratori
failur
secondari
immunopatholog
injuri
like
due
combin
direct
cytopath
effect
viru
concert
aberr
immun
respons
interplay
two
compon
recent
better
understood
inde
genom
encod
eight
accessori
protein
design
open
read
frame
orf
identifi
function
particular
protein
initi
necroptosi
oligomer
allow
form
potassiumsensit
channel
insert
late
endosom
lysosom
transgolginetwork
membran
oligomer
play
critic
role
drive
necrot
cell
death
independ
hijack
necroptot
signal
consider
evid
abund
necroptosi
perpetu
pathogen
inflamm
drive
tissu
injuri
fatal
case
infect
similarli
show
signific
lung
damag
respons
inflamm
may
well
driven
necroptosi
effect
cell
surviv
death
may
vari
depend
cell
type
concentr
diseas
condit
contrast
lowphysiolog
dose
high
level
usual
trigger
activ
necroptot
gene
express
reason
pulmonari
arteri
hypertens
patient
may
prone
activ
necroptot
pathway
furthermor
inflammatori
endotoxem
stress
condit
sever
acut
respiratori
syndrom
mediat
effect
shift
promot
necroptosi
potent
long
last
activ
therebi
enhanc
oligomer
protein
increas
catastroph
effect
proinflammatori
necroptot
cell
death
pathogenesi
block
et
receptor
bosentan
abl
inhibit
necroptosi
pathway
experiment
model
microvascular
endotheli
cell
endothelin
receptor
antagonist
counteract
viciou
circl
activ
propag
proinflammatori
necroptot
cell
death
happen
worst
form
sar
propos
seem
safe
continu
endothelin
receptor
antagonist
patient
treatment
class
drug
